XML 44 R31.htm IDEA: XBRL DOCUMENT
v3.22.1

Equity Incentive Plans (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
Schedule of Restricted Stock Units Activity | A summary of the RSUs awarded to employees, directors and consultants under the 2017 Equity Plan during the years ended December 31, 2021 and 2020 are presented in the table below: Schedule of Restricted Stock Units Activity
|  | Number of Units |  |  | Weighted Average Grant-Date Fair Value |  |  | Aggregate Intrinsic Value |
Outstanding, December 31, 2019 |  |  | 50,333 |  |  | $ | 19.20 |  |  | $ | - |
Granted |  |  | - |  |  |  | - |  |  |  |  |
Vested and settled with share issuance |  |  | (45,00 | ) |  | $ | 18.15 |  |  |  |  |
Forfeited/cancelled |  |  | (5,333 | ) |  | $ | 23.10 |  |  |  |  |
Outstanding, December 31, 2020 |  |  | - |  |  |  |  |  |  | $ | - |
Granted |  |  | - |  |  |  |  |  |  |  |  |
Vested and settled with share issuance |  |  | - |  |  |  |  |  |  |  |  |
Forfeited/cancelled |  |  | - |  |  |  |  |  |  |  |  |
Outstanding, December 31, 2021 |  |  | - |  |  |  |  |  |  | $ | - |
2017 Equity Incentive Plan [Member] | Employees And Consultants [Member] |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
Schedule of Stock Option Activity | A summary of the stock options granted to employees and consultants under the 2017 Equity Plan and the 2021 Equity Incentive Plan during the years ended December 31, 2021 and 2020 are presented in the table below: Schedule of Stock Option Activity
|  | Number of Options |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term |  |  | Aggregate Intrinsic Value |
Outstanding, December 31, 2019 |  |  | 67,567 |  |  | $ | 14.40 |  |  |  | 7.7 |  |  | $ | - |
Granted |  |  | 44,113 |  |  | $ | 10.50 |  |  |  | 10.0 |  |  |  |  |
Exercised |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Forfeited |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Expired |  |  | (16,673 | ) |  | $ | 15.15 |  |  |  | 4.3 |  |  |  |  |
Outstanding, December 31, 2020 |  |  | 95,007 |  |  | $ | 12.45 |  |  |  | 7.1 |  |  | $ | - |
Granted |  |  | 65,508 |  |  | $ | 9.00 |  |  |  | 10.0 |  |  | $ | - |
Exercised |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Forfeited |  |  | (2,341 | ) |  | $ | 16.83 |  |  |  | 7.0 |  |  | $ | - |
Expired |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Outstanding, December 31, 2021 |  |  | 158,174 |  |  | $ | 10.99 |  |  |  | 7.6 |  |  | $ | - |
Exercisable, December 31, 2021 |  |  | 116,328 |  |  | $ | 12.12 |  |  |  | 6.8 |  |  | $ | - |
Summary of Non-vested Non-qualified Stock Option Activity | A summary of non-vested stock options activity for employees and consultants under the 2017 Equity Plan and the 2021 Equity Plan for the years ended December 31, 2021 and 2020 are presented in the table below: Summary of Non-vested Non-qualified Stock Option Activity
﻿ |  | Number of Options |  |  | Weighted Average Grant-Date Fair Value |  |  | Aggregate Intrinsic Value |  |  | Grant-Date Fair Value |
﻿ |  |  |  |  |  |  |  |  |  |  |  |
Nonvested, December 31, 2019 |  |  | 13,333 |  |  | $ | 11.25 |  |  | $ | - |  |  | $ | 149,534 |
Granted |  |  | 44,113 |  |  | $ | 8.85 |  |  |  |  |  |  | $ | 387,199 |
Vested |  |  | (57,446 | ) |  | $ | 9.30 |  |  |  |  |  |  | $ | 536,733 |
Forfeited |  |  | - |  |  |  |  |  |  |  |  |  |  | $ | - |
Expired |  |  | - |  |  |  |  |  |  |  |  |  |  | $ | - |
Nonvested, December 31, 2020 |  |  | - |  |  | $ | - |  |  | $ | - |  |  | $ | - |
Granted |  |  | 65,508 |  |  | $ | 8.85 |  |  | $ | - |  |  | $ | 575,711 |
Vested |  |  | (23,662 | ) |  | $ | 10.65 |  |  | $ | - |  |  | $ | (252,571 | )
Forfeited |  |  | - |  |  |  |  |  |  |  |  |  |  | $ | - |
Expired |  |  | - |  |  |  |  |  |  |  |  |  |  | $ | - |
Nonvested, December 31, 2021 |  |  | 41,846 |  |  | $ | 7.65 |  |  | $ | - |  |  | $ | 323,140 |
2017 Equity Plan and 2021 Equity Plan [Member] | Directors [Member] |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
Schedule of Stock Option Activity | A summary of the non-qualified stock options granted to directors under the 2017 Equity Plan and 2021 Equity Plan during the years ended December 31, 2021 and 2020 are presented in the table below: Schedule of Stock Option Activity
|  | Number of Options |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term |  |  | Aggregate Intrinsic Value ($000) |
Outstanding, December 31, 2019 |  |  | 6,000 |  |  | $ | 20.25 |  |  |  | 7.6 |  |  | $ | - |
Granted |  |  | 43,333 |  |  | $ | 8.55 |  |  |  | 8.5 |  |  |  |  |
Exercised |  |  | - |  |  |  | - |  |  |  |  |  |  |  |  |
Forfeited/Cancelled |  |  | - |  |  |  | - |  |  |  |  |  |  |  |  |
Expired |  |  | - |  |  |  | - |  |  |  |  |  |  |  |  |
Outstanding, December 31, 2020 |  |  | 49,333 |  |  | $ | 10.05 |  |  |  | 4.5 |  |  | $ | - |
Granted |  |  | 1,539 |  |  | $ | 9.75 |  |  |  | 10.0 |  |  | $ | - |
Exercised |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Forfeited/Cancelled |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Expired |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Outstanding, December 31, 2021 |  |  | 50,872 |  |  | $ | 10.02 |  |  |  | 6.6 |  |  | $ | - |
Exercisable, December 31, 2021 |  |  | 50,872 |  |  | $ | 10.02 |  |  |  | 6.6 |  |  | $ | - |
Summary of Non-vested Non-qualified Stock Option Activity | A summary of non-vested non-qualified stock options activity for directors under the 2017 Equity Plan and the 2021 Equity Plan for the years ended December 31, 2021 and 2020 are presented in the table below: Summary of Non-vested Non-qualified Stock Option Activity
﻿ |  | Number of Options |  |  | Weighted Average Grant-Date Fair Value |  |  | Aggregate Intrinsic Value |  |  | Grant-Date Fair Value |
﻿ |  |  |  |  |  |  |  |  |  |  |  |
Nonvested, December 31, 2019 |  |  | - |  |  |  | - |  |  | $ | - |  |  |  |  |
Granted |  |  | 43,333 |  |  | $ | 8.55 |  |  |  |  |  |  | $ | 373,000 |
Vested |  |  | (36,667 | ) |  | $ | 9.45 |  |  |  |  |  |  | $ | 344,000 |
Forfeited |  |  | - |  |  |  | - |  |  |  |  |  |  | $ | - |
Expired |  |  | - |  |  |  | - |  |  |  |  |  |  | $ | - |
Nonvested, December 31, 2020 |  |  | 6,666 |  |  | $ | 4.35 |  |  | $ | 3,400 |  |  | $ | 29,000 |
Granted |  |  | 1,539 |  |  | $ | 9.75 |  |  | $ |  |  |  | $ | 15,000 |
Vested |  |  | (8,205 | ) |  | $ | 5.40 |  |  | $ | 4,431 |  |  | $ | (44,000 | )
Forfeited |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Expired |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |
Nonvested, December 31, 2021 |  |  | - |  |  |  |  |  |  | $ | - |  |  | $ | - |

X
- Definition Tabular disclosure of the changes in outstanding nonvested shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_PlanNameAxis=CEAD_TwoThousandAndSeventeenEquityPlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=CEAD_EmployeesAndConsultantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PlanNameAxis=CEAD_TwoThousandAndSeventeenEquityPlanAndTwoThousandAndTwentyOneEquityPlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=CEAD_DirectorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |